Cardlytics Inc (CDLX) Stock Price, Quote & News

Latest News on CDLX

Apr 23, 2025, 4:05 PM EDT - 14 hours ago

Cardlytics Announces Timing of Its First Quarter 2025 Earnings Release

Mar 15, 2025, 7:35 AM EDT - 5 weeks ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics

Mar 13, 2025, 10:52 AM EDT - 5 weeks ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics

Mar 12, 2025, 7:47 PM EDT - 6 weeks ago

Cardlytics, Inc. (CDLX) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 4:05 PM EDT - 6 weeks ago

Cardlytics Announces Fourth Quarter and Full Year 2024 Financial Results

Mar 3, 2025, 5:45 AM EST - 7 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Cardlytics, Inc. Lawsuit - CDLX

Feb 28, 2025, 4:05 PM EST - 7 weeks ago

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Feb 27, 2025, 5:45 AM EST - 7 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Cardlytics Lawsuit - CDLX

Feb 26, 2025, 4:05 PM EST - 2 months ago

Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2024 Earnings Release

Feb 25, 2025, 11:27 AM EST - 2 months ago

Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections - Hagens Berman

Feb 24, 2025, 3:01 PM EST - 2 months ago

Cardlytics (CDLX) Faces Investor Lawsuit Over Growth Projections – Hagens Berman

Feb 18, 2025, 8:09 PM EST - 2 months ago

Robbins LLP Reminds Investors of Cardlytics, Inc. (CDLX) of the Pending Lead Plaintiff Deadline and Urges Investors to Obtain Counsel

Feb 13, 2025, 12:47 PM EST - 2 months ago

Cardlytics: Short-Term Headwinds Drive Long-Term Success

Feb 10, 2025, 5:45 AM EST - 2 months ago

Shareholders of Cardlytics, Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - CDLX

Feb 6, 2025, 5:45 AM EST - 2 months ago

Investors in Cardlytics, Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - CDLX

Feb 4, 2025, 6:30 PM EST - 2 months ago

Cardlytics, Inc. Is Being Sued For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm

Feb 3, 2025, 11:31 AM EST - 2 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Cardlytics Lawsuit – CDLX

Feb 2, 2025, 11:00 AM EST - 2 months ago

Cardlytics, Inc. Is Being Sued For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Jan 29, 2025, 10:27 AM EST - 3 months ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cardlytics

Jan 27, 2025, 10:25 AM EST - 3 months ago

Rosen Law Firm Urges Cardlytics, Inc. (NASDAQ: CDLX) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Jan 26, 2025, 11:45 AM EST - 3 months ago

Cardlytics, Inc. Is Being Investigated For Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm

Jan 24, 2025, 7:00 PM EST - 3 months ago

Cardlytics, Inc. Announcement: If You Have Suffered Losses in Cardlytics, Inc. (NASDAQ: CDLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Jan 24, 2025, 11:30 AM EST - 3 months ago

Cardlytics, Inc. Is Being Investigated For Securities Fraud And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Jan 22, 2025, 11:15 AM EST - 3 months ago

Market Cap	80.21M
Revenue (ttm)	278.30M
Net Income (ttm)	-189.30M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-68.02%
Debt to Equity Ratio	0.66

Volume	478,100
Avg Vol	1,066,794
Day's Range	N/A - N/A
Shares Out	52.09M
Stochastic %K	64%
Beta	1.39
Analysts	Sell
Price Target	$5.10